Cell Reports (Jan 2012)

Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions

  • Hsien-Yang Lee,
  • Yong Huang,
  • Nadine Bruneau,
  • Patrice Roll,
  • Elisha D.O. Roberson,
  • Mark Hermann,
  • Emily Quinn,
  • James Maas,
  • Robert Edwards,
  • Tetsuo Ashizawa,
  • Betul Baykan,
  • Kailash Bhatia,
  • Susan Bressman,
  • Michiko K. Bruno,
  • Ewout R. Brunt,
  • Roberto Caraballo,
  • Bernard Echenne,
  • Natalio Fejerman,
  • Steve Frucht,
  • Christina A. Gurnett,
  • Edouard Hirsch,
  • Henry Houlden,
  • Joseph Jankovic,
  • Wei-Ling Lee,
  • David R. Lynch,
  • Shehla Mohammed,
  • Ulrich Müller,
  • Mark P. Nespeca,
  • David Renner,
  • Jacques Rochette,
  • Gabrielle Rudolf,
  • Shinji Saiki,
  • Bing-Wen Soong,
  • Kathryn J. Swoboda,
  • Sam Tucker,
  • Nicholas Wood,
  • Michael Hanna,
  • Anne M. Bowcock,
  • Pierre Szepetowski,
  • Ying-Hui Fu,
  • Louis J. Ptáček

DOI
https://doi.org/10.1016/j.celrep.2011.11.001
Journal volume & issue
Vol. 1, no. 1
pp. 2 – 12

Abstract

Read online

Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) is an episodic movement disorder with autosomal-dominant inheritance and high penetrance, but the causative genetic mutation is unknown. We have now identified four truncating mutations involving the gene PRRT2 in the vast majority (24/25) of well-characterized families with PKD/IC. PRRT2 truncating mutations were also detected in 28 of 78 additional families. PRRT2 encodes a proline-rich transmembrane protein of unknown function that has been reported to interact with the t-SNARE, SNAP25. PRRT2 localizes to axons but not to dendritic processes in primary neuronal culture, and mutants associated with PKD/IC lead to dramatically reduced PRRT2 levels, leading ultimately to neuronal hyperexcitability that manifests in vivo as PKD/IC.